Development and commercialisation capital, funding advanced preclinical / phase I-II clinical stage and medical device feasibility/pivotal stage healthcare and biomedical companies.
Investment in Australian public and private companies.
Number of investments
To date, 5 investments have been made and it is expected that up to 8 to 12 investments in eligible companies can be made. BioScience Managers are actively seeking new investment opportunities for this fund.